# Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants

> **NCT07512427** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **OPKO Health, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- MASH

## Interventions

- **DRUG:** OPK-88006
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07512427
- **Lead sponsor:** OPKO Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07512427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07512427, "Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07512427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*